m. f. johnson et al.table 2. summary of immune cell types implicated in preserving insulin sensitivitygains in galectin-3-deficient mice compared to controls were also reported by pejnovic et al.

m. f. johnson et al.wen h gris d lei y jha s et al.

genes dev 21 1443-55.boulange cl neves al chilloux j nicholson jk et al.

specifically galectin-3-deficient mice and wild-type mice administered with a galectin-3 inhibitor were insulin sensitive whereas administration of recombinant galectin-3 made mice insulin resistant and in vitro treatment of hepatocytes adipocytes or myocytes with galectin-3 resulted in insulin resistance 6. this is broadly similar to data reported by baek et al.

in contrast pang et al.

one recent study by kraakman et al.

2016zx310190 and 2016zx320014.the authors have declared no conflicts of interest.referencesorganization wh tareque mi koshio a tiedt ad et al.

immunity 41 36-48.li p liu s lu m bandyopadhyay g et al.

cell 167 973-84. e12.dominguez h storgaard h rask-madsen c hermann ts et al.

j vasc res 42 517-25.bernstein le berry j kim s canavan b et al.

science 259 87-91.xu h barnes gt yang q tan g et al.

j clin invest 112 1821-30.weisberg sp mccann d desai m rosenbaum m et al.

j clin invest 112 1796-808.obstfeld ae sugaru e thearle m francisco a et al.

diabetes 59 916.varma v yao-borengasser a rasouli n nolen gt et al.

am j physiol endocrinol metab 296 e1300-10.ehses ja perren a eppler e ribaux p et al.

